Telehealth Referral to Improve Outcomes for Asymptomatic Hypertension in the Emergency Department
Overview
- Phase
- Not Applicable
- Status
- Suspended
- Enrollment
- 48
- Locations
- 1
- Primary Endpoint
- Retention rate
Overview
Brief Summary
Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the emergency department. This 3-arm randomized controlled trial will evaluate the impact of nurse telehealth encounters and remote patient monitoring, using a software called Vital Tech, on blood pressure control and primary care engagement.
Detailed Description
Emergency Department (ED) clinicians encounter patients with asymptomatic hypertension (HTN) on a daily basis but usually fail to intervene. This pilot study will determine the utility of a novel intervention: Telehealth Referral to Improve Outcomes (TRIO), a conceptually driven information technology tool focused on patients who are asymptomatic and hypertensive upon ED discharge. It is designed to successfully link them to a primary care provider (PCP) after ED discharge to improve blood pressure (BP) control. 48 adult ED patients who have asymptomatic HTN (BP >/= 140/90 mmg and </= 180/120 mmHg) and who will be discharged will be enrolled in the study. This study is a single-site, 3-arm randomized controlled pilot trial. All patients will receive a wireless BP monitor and tablet. Group 2 (N=16) will additionally receive a telehealth consult with an RN at day 3. Group 3 (N=16) will additionally receive a telehealth consult with an RN at day 3 and day 7. The research team will collect feasibility outcomes: (recruitment rate, retention rate, and attrition rate of patients enrolled in TRIO at 6-months and 12-months. The research team will evaluate BP control and engagement with primary care at 6-months and 12-months and compare between groups.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Factorial
- Primary Purpose
- Prevention
- Masking
- Double (Participant, Investigator)
Masking Description
Both participant and investigator will be blinded on the study assignment group.
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age ≥ 18 years
- •At least two\* high blood pressure readings during ED visit
- •Systolic (top #) ≥140, ≤180 AND/OR
- •Diastolic (bottom #) ≥ 90, ≤120
- •\*Second blood pressure may be confirmed when approaching the patient. Before approaching, check exclusions first.
Exclusion Criteria
- •symptomatic hypertension
Outcomes
Primary Outcomes
Retention rate
Time Frame: 12 months
retention rate of patients enrolled in TRIO at 12-months.
Recruitment rate
Time Frame: 12 months
recruitment rate of patients enrolled in TRIO at 12-months.
Attrition rate
Time Frame: 12 months
attrition rate of patients enrolled in TRIO at 12-months.
Secondary Outcomes
- Number of participant who had follow up care(12 months)
- Blood pressure(12 months)
Investigators
Kimberly T Souffront
Principal Investigator
Icahn School of Medicine at Mount Sinai